Selected research
Market Structure
Global Cutting Biopsy System For Breast Lesion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Cutting Biopsy System For Breast Lesion market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Cutting Biopsy System For Breast Lesion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Cutting Biopsy System For Breast Lesion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cutting Biopsy System For Breast Lesion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Cutting Biopsy System For Breast Lesion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cutting Biopsy System For Breast Lesion include BD, Danaher Corporation, Cultiva Medical, Chongqing Xishan Science & Technology and GMT Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Cutting Biopsy System For Breast Lesion market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Cutting Biopsy System For Breast Lesion and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Cutting Biopsy System For Breast Lesion revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cutting Biopsy System For Breast Lesion market size, projected growth trends, production technologies, key applications, and end-use industries.
Cutting Biopsy System For Breast Lesion Segment by Company
BD
Danaher Corporation
Cultiva Medical
Chongqing Xishan Science & Technology
GMT Medical
Cutting Biopsy System For Breast Lesion Segment by Type
Half Cut
Full Cut
Cutting Biopsy System For Breast Lesion Segment by Application
Malignant Breast Tumors
Benign Breast Tumors
Cutting Biopsy System For Breast Lesion Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cutting Biopsy System For Breast Lesion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cutting Biopsy System For Breast Lesion and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cutting Biopsy System For Breast Lesion.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cutting Biopsy System For Breast Lesion in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cutting Biopsy System For Breast Lesion industry.
Chapter 3: Detailed analysis of Cutting Biopsy System For Breast Lesion companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cutting Biopsy System For Breast Lesionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Half Cut
- Full Cut
Applications
- Malignant Breast Tumors
- Benign Breast Tumors
Companies covered
- BD
- Danaher Corporation
- Cultiva Medical
- Chongqing Xishan Science & Technology
- GMT Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Cutting Biopsy System For Breast Lesion Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Half Cut
- 1.2.3 Full Cut
- 1.3 Market Analysis by Application
- 1.3.1 Global Cutting Biopsy System For Breast Lesion Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Malignant Breast Tumors
- 1.3.3 Benign Breast Tumors
- 1.4 Global Market Growth Prospects
- 1.5 Global Cutting Biopsy System For Breast Lesion Growth Trends by Region
- 1.5.1 Global Cutting Biopsy System For Breast Lesion Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Cutting Biopsy System For Breast Lesion Market Size by Region (2021-2026)
- 1.5.3 Cutting Biopsy System For Breast Lesion Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Cutting Biopsy System For Breast Lesion Market Dynamics
- 2.1 Cutting Biopsy System For Breast Lesion Industry Trends
- 2.2 Cutting Biopsy System For Breast Lesion Industry Drivers
- 2.3 Cutting Biopsy System For Breast Lesion Industry Opportunities and Challenges
- 2.4 Cutting Biopsy System For Breast Lesion Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Cutting Biopsy System For Breast Lesion Revenue by Company (2021-2026)
- 3.2 Global Cutting Biopsy System For Breast Lesion Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Cutting Biopsy System For Breast Lesion Key Company Head office and Area Served
- 3.4 Global Cutting Biopsy System For Breast Lesion Company, Product Type & Application
- 3.5 Global Cutting Biopsy System For Breast Lesion Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Cutting Biopsy System For Breast Lesion Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Cutting Biopsy System For Breast Lesion Players Market Share by Revenue in 2025
- 3.6.3 2025 Cutting Biopsy System For Breast Lesion Tier 1, Tier 2, and Tier 3
4 Cutting Biopsy System For Breast Lesion Market by Type
- 4.1 Global Cutting Biopsy System For Breast Lesion Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Cutting Biopsy System For Breast Lesion Market Size by Type (2021-2032)
- 4.3 Global Cutting Biopsy System For Breast Lesion Market Size Share by Type (2021-2032)
5 Cutting Biopsy System For Breast Lesion Market by Application
- 5.1 Global Cutting Biopsy System For Breast Lesion Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Cutting Biopsy System For Breast Lesion Market Size by Application (2021-2032)
- 5.3 Global Cutting Biopsy System For Breast Lesion Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 BD
- 6.1.1 BD Company Information
- 6.1.2 BD Business Overview
- 6.1.3 BD Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 BD Cutting Biopsy System For Breast Lesion Product Portfolio
- 6.1.5 BD Recent Developments
- 6.2 Danaher Corporation
- 6.2.1 Danaher Corporation Company Information
- 6.2.2 Danaher Corporation Business Overview
- 6.2.3 Danaher Corporation Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Danaher Corporation Cutting Biopsy System For Breast Lesion Product Portfolio
- 6.2.5 Danaher Corporation Recent Developments
- 6.3 Cultiva Medical
- 6.3.1 Cultiva Medical Company Information
- 6.3.2 Cultiva Medical Business Overview
- 6.3.3 Cultiva Medical Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Cultiva Medical Cutting Biopsy System For Breast Lesion Product Portfolio
- 6.3.5 Cultiva Medical Recent Developments
- 6.4 Chongqing Xishan Science & Technology
- 6.4.1 Chongqing Xishan Science & Technology Company Information
- 6.4.2 Chongqing Xishan Science & Technology Business Overview
- 6.4.3 Chongqing Xishan Science & Technology Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Chongqing Xishan Science & Technology Cutting Biopsy System For Breast Lesion Product Portfolio
- 6.4.5 Chongqing Xishan Science & Technology Recent Developments
- 6.5 GMT Medical
- 6.5.1 GMT Medical Company Information
- 6.5.2 GMT Medical Business Overview
- 6.5.3 GMT Medical Cutting Biopsy System For Breast Lesion Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 GMT Medical Cutting Biopsy System For Breast Lesion Product Portfolio
- 6.5.5 GMT Medical Recent Developments
7 North America
- 7.1 North America Cutting Biopsy System For Breast Lesion Market Size (2021-2032)
- 7.2 North America Cutting Biopsy System For Breast Lesion Market Size by Type
- 7.2.1 North America Cutting Biopsy System For Breast Lesion Market Size by Type (2021-2026)
- 7.2.2 North America Cutting Biopsy System For Breast Lesion Market Size by Type (2027-2032)
- 7.2.3 North America Cutting Biopsy System For Breast Lesion Market Share by Type (2021-2032)
- 7.3 North America Cutting Biopsy System For Breast Lesion Market Size by Application
- 7.3.1 North America Cutting Biopsy System For Breast Lesion Market Size by Application (2021-2026)
- 7.3.2 North America Cutting Biopsy System For Breast Lesion Market Size by Application (2027-2032)
- 7.3.3 North America Cutting Biopsy System For Breast Lesion Market Share by Application (2021-2032)
- 7.4 North America Cutting Biopsy System For Breast Lesion Market Size by Country
- 7.4.1 North America Cutting Biopsy System For Breast Lesion Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Cutting Biopsy System For Breast Lesion Market Size by Country (2021-2026)
- 7.4.3 North America Cutting Biopsy System For Breast Lesion Market Size by Country (2027-2032)
- 7.4.4 North America Cutting Biopsy System For Breast Lesion Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Cutting Biopsy System For Breast Lesion Market Size (2021-2032)
- 8.2 Europe Cutting Biopsy System For Breast Lesion Market Size by Type
- 8.2.1 Europe Cutting Biopsy System For Breast Lesion Market Size by Type (2021-2026)
- 8.2.2 Europe Cutting Biopsy System For Breast Lesion Market Size by Type (2027-2032)
- 8.2.3 Europe Cutting Biopsy System For Breast Lesion Market Share by Type (2021-2032)
- 8.3 Europe Cutting Biopsy System For Breast Lesion Market Size by Application
- 8.3.1 Europe Cutting Biopsy System For Breast Lesion Market Size by Application (2021-2026)
- 8.3.2 Europe Cutting Biopsy System For Breast Lesion Market Size by Application (2027-2032)
- 8.3.3 Europe Cutting Biopsy System For Breast Lesion Market Share by Application (2021-2032)
- 8.4 Europe Cutting Biopsy System For Breast Lesion Market Size by Country
- 8.4.1 Europe Cutting Biopsy System For Breast Lesion Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Cutting Biopsy System For Breast Lesion Market Size by Country (2021-2026)
- 8.4.3 Europe Cutting Biopsy System For Breast Lesion Market Size by Country (2027-2032)
- 8.4.4 Europe Cutting Biopsy System For Breast Lesion Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Cutting Biopsy System For Breast Lesion Market Size (2021-2032)
- 9.2 China Cutting Biopsy System For Breast Lesion Market Size by Type
- 9.2.1 China Cutting Biopsy System For Breast Lesion Market Size by Type (2021-2026)
- 9.2.2 China Cutting Biopsy System For Breast Lesion Market Size by Type (2027-2032)
- 9.2.3 China Cutting Biopsy System For Breast Lesion Market Share by Type (2021-2032)
- 9.3 China Cutting Biopsy System For Breast Lesion Market Size by Application
- 9.3.1 China Cutting Biopsy System For Breast Lesion Market Size by Application (2021-2026)
- 9.3.2 China Cutting Biopsy System For Breast Lesion Market Size by Application (2027-2032)
- 9.3.3 China Cutting Biopsy System For Breast Lesion Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Cutting Biopsy System For Breast Lesion Market Size (2021-2032)
- 10.2 Asia Cutting Biopsy System For Breast Lesion Market Size by Type
- 10.2.1 Asia Cutting Biopsy System For Breast Lesion Market Size by Type (2021-2026)
- 10.2.2 Asia Cutting Biopsy System For Breast Lesion Market Size by Type (2027-2032)
- 10.2.3 Asia Cutting Biopsy System For Breast Lesion Market Share by Type (2021-2032)
- 10.3 Asia Cutting Biopsy System For Breast Lesion Market Size by Application
- 10.3.1 Asia Cutting Biopsy System For Breast Lesion Market Size by Application (2021-2026)
- 10.3.2 Asia Cutting Biopsy System For Breast Lesion Market Size by Application (2027-2032)
- 10.3.3 Asia Cutting Biopsy System For Breast Lesion Market Share by Application (2021-2032)
- 10.4 Asia Cutting Biopsy System For Breast Lesion Market Size by Country
- 10.4.1 Asia Cutting Biopsy System For Breast Lesion Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Cutting Biopsy System For Breast Lesion Market Size by Country (2021-2026)
- 10.4.3 Asia Cutting Biopsy System For Breast Lesion Market Size by Country (2027-2032)
- 10.4.4 Asia Cutting Biopsy System For Breast Lesion Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Size by Type
- 11.2.1 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Size by Application
- 11.3.1 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Size by Country
- 11.4.1 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Cutting Biopsy System For Breast Lesion Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst